Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
about
MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerA Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression.Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.Triple-negative breast cancer: treatment challenges and solutions.Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about "Triple-negative breast cancer: treatment challenges and solutions" by Collignon et alThe prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.Risk Factors and Preventions of Breast Cancer.PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer.Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancerThe preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer
P2860
Q26775086-DE3AF6B1-E985-4B33-8371-3E78EDD5B790Q34550256-5FC9957C-86BD-4EB9-8A1B-BEDEDBEE9046Q36860111-AE5BED7F-4E7D-467B-A3AD-8BA5A3531D0FQ36908403-98496786-30C0-4536-B230-EDFB6592E990Q36940085-F540F8F8-0B8F-4BC7-83BC-D3ADA533850DQ38552128-9DD49FC0-7A50-474A-9596-EC7083B8EE3AQ38942073-FB5783E0-EE7A-4EB4-96D1-EE1384171D20Q46842412-C9E1BF38-A38E-4851-9CDA-788DA5E9F0C2Q47100005-D2EDB087-B19A-47F4-AF4B-C587490062E2Q55001013-CD0058CE-EDE2-438D-9B55-D83BB7700438Q55266544-5F2D7123-5772-4BC3-9A05-B52EF7E907AEQ58740515-2B33147E-7767-4B23-B292-F0C6C111A9C3Q58755561-BDEAE7AA-CAB1-40DB-AC20-3E1B9C799650
P2860
Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Is androgen receptor targeting ...... triple negative breast cancer?
@ast
Is androgen receptor targeting ...... triple negative breast cancer?
@en
Is androgen receptor targeting ...... triple negative breast cancer?
@nl
type
label
Is androgen receptor targeting ...... triple negative breast cancer?
@ast
Is androgen receptor targeting ...... triple negative breast cancer?
@en
Is androgen receptor targeting ...... triple negative breast cancer?
@nl
prefLabel
Is androgen receptor targeting ...... triple negative breast cancer?
@ast
Is androgen receptor targeting ...... triple negative breast cancer?
@en
Is androgen receptor targeting ...... triple negative breast cancer?
@nl
P2093
P1476
Is androgen receptor targeting ...... triple negative breast cancer?
@en
P2093
Aristomenis Anestis
Athanasios G Papavassiliou
Georgia Dalagiorgou
Michalis V Karamouzis
P304
P356
10.1016/J.CTRV.2015.04.009
P577
2015-04-29T00:00:00Z